Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Valion Bio(VBIO) the EBIT is -6.424 M (-282.8%);the EPS is -2.17 (+0.82%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.01B282.84%
----
----
EPS
-2.17430.82%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf